The World's Most Neglected Disease

Key Takeaways

• Hypertension prevalence doubled since 2000, now over 1 billion untreated.
• Control rates fell to 10% in low‑ and middle‑income nations.
• Sodium excess and potassium deficiency drive global blood‑pressure rise.
• WHO HEARTS package offers three‑drug protocol and team‑based care.
• $5 per patient yearly prevents strokes, yields eight‑fold government savings.

Pulse Analysis

Hypertension remains the world’s deadliest yet most neglected disease, responsible for over 10 million deaths each year—more than HIV, tuberculosis and malaria combined. The latest global review, covering 6.1 million adults in 119 countries, reveals a stark divergence: high‑income economies have trimmed prevalence and doubled control rates to 40%, while low‑ and middle‑income regions now see prevalence climbing and control languishing at just 10%. This widening gap threatens to push the global hypertensive population beyond 2 billion by 2030, amplifying the burden on fragile health systems.

Dietary factors lie at the heart of the crisis. Excessive sodium consumption, paired with chronic potassium deficiency, drives blood‑pressure spikes across populations. Evidence shows mandatory sodium limits on processed foods and front‑of‑pack warning labels can cut intake substantially, whereas voluntary industry pledges have little impact. Substituting regular salt with potassium‑enriched alternatives could avert hundreds of thousands of strokes annually at minimal cost. Policymakers therefore have a clear, evidence‑based toolkit to curb the epidemic without massive fiscal outlays.

The WHO HEARTS technical package translates these insights into actionable steps: a simple three‑medicine protocol, reliable generic drug supplies, team‑based care, free patient‑centered treatment, and systematic tracking of control rates. Partners like Resolve to Save Lives embed technical expertise, train health workers, and secure supply chains in over 40 countries, delivering medication for under $5 per patient per year. Their catalytic model leverages roughly eight dollars of public spending for every philanthropic dollar, offering one of the highest returns in global health. Scaling such proven interventions promises to shrink mortality, boost productivity, and alleviate the looming economic toll of uncontrolled hypertension.